Applications of Cholesteryl Sulfate Potassium Salt in Industrial Manufacturing

Cholesteryl sulfate potassium salt provides distinctive amphiphilic and ionic properties, making it valuable in select high-performance industrial processes requiring precise membrane manipulation, formulation stability, or specialized surfactant action. We supply this raw material directly to qualified manufacturers, supporting compliance, traceability, and batch-to-batch consistency. The following scenarios highlight established, real-world downstream applications with clear formulation and regulatory parameters.

1. Liposome Stabilization for Pharmaceutical Formulations

In pharmaceutical industries, manufacturers use cholesteryl sulfate potassium salt as a charged membrane stabilizer during liposome encapsulation for injectable or topical drug delivery systems. Its sulfate group provides negative surface charge, effectively reducing vesicle aggregation and leakage through electrostatic repulsion. This approach is especially valuable for enhancing the stability and circulation time of liposomal drugs containing hydrophobic actives.

Industry compliance standards

• United States Pharmacopeia (USP) monograph requirements for liposome-based drug components
• European Pharmacopoeia (Ph. Eur.) lipid excipient purity and microbial limits
• Current Good Manufacturing Practices (cGMP) for sterile injectable drugs
• ICH Q3C Residual Solvents and Q6A Specifications

Typical usage ratio

• 0.5%–4% w/w based on total lipid phase, adjusted depending on the active pharmaceutical ingredient (API), desired vesicle charge, and liposome bilayer composition

Downstream process integration

• Added directly to the lipid phase during solvent evaporation or ethanol injection prior to vesicle formation and sonication
• Homogeneously dispersed with other lipids before hydration and sizing

Final product types

• Liposomal injectable formulations (e.g., anticancer drugs, antifungal agents)
• Topical liposomal gels and creams
• Oral liposome suspensions for enhanced bioavailability

2. Ophthalmic Emulsion Stabilization

Ophthalmic manufacturers apply cholesteryl sulfate potassium salt to reinforce the interface of oil-in-water emulsions used in prescription and OTC eye drops. Its ionic surfactant profile reduces coalescence and supports reproducible droplet size distribution, which are essential for formulations carrying sensitive actives for dry eye or anti-inflammatory purposes while ensuring patient safety at the ocular surface.

Industry compliance standards

• U.S. FDA 21 CFR Part 210/211 (cGMP for Finished Pharmaceuticals)
• ISO 10993-5 Cytotoxicity Assessment for ophthalmic products
• EP/USP excipient guidelines for ophthalmic-grade surfactants
• FDA Inactive Ingredient Database (for approved levels in ophthalmic formulations)

Typical usage ratio

• 0.1%–0.6% w/v relative to total emulsion mass, with adjustments for the nature and concentration of lipophilic components

Downstream process integration

• Incorporated during the primary emulsification step alongside oil phase, prior to high-pressure homogenization
• May serve as a co-surfactant in complex multi-phase systems with phospholipids or polysorbates

Final product types

• Prescription cyclosporine eye drop emulsions
• Artificial tear lipid nanoemulsions
• Multiphase preservative-free ophthalmic solutions

3. Diagnostic Reagent Stabilization

Companies engaged in in-vitro diagnostics utilize cholesteryl sulfate potassium salt in buffered solutions that require highly stable liposome or protein-lipid assemblies. The material enhances the shelf-life and reliability of diagnostic reagents by preventing non-specific aggregation and supporting uniform analytical results, particularly in immunoassay kits using lipid vesicle carriers or latex bead suspensions.

Industry compliance standards

• ISO 13485 Quality Management Systems for Medical Devices
• FDA 21 CFR Part 820 (QSR for Medical Devices)
• CLSI (Clinical & Laboratory Standards Institute) protocols for in-vitro diagnostic reagents
• REACH Annex II (for documentation in EU diagnostics markets)

Typical usage ratio

• 0.2%–2% w/w with respect to lipid or protein carrier matrix, tailored to vesicle or particle concentration and assay requirements

Downstream process integration

• Added to formulation buffer before assembly or encapsulation of diagnostic carrier systems
• Mixed during extrusion or ultrasonic processing of liposomes for uniform dispersion

Final product types

• Immunoassay panels (ELISA, lateral flow tests)
• Liposome-encapsulated marker beads for IVD kits
• Calibrator and control reagents for automated analyzers

4. Membrane Research for Biotech and Academia

Biotechnology and academic R&D labs source cholesteryl sulfate potassium salt to mimic negatively charged biological membranes in biophysical studies and protein-membrane interaction research. Its use provides reference models for neurological membrane assays and the investigation of membrane-active compounds under physiologically relevant conditions, without introducing unwanted permeability or artifacts in electrical or spectroscopic measurements.

Industry compliance standards

• GLP (Good Laboratory Practice) guidelines for research reagents
• ISO 9001:2015 Quality Management for lab chemical production
• Material transfer and chemical registration for academic research in EU/US
• OECD Principles of Good Laboratory Practice

Typical usage ratio

• 0.5%–5% molar ratio relative to total lipid content in artificial membrane systems, determined by experimental design and target charge density

Downstream process integration

• Blended into dry lipid films before hydration for vesicle or planar bilayer formation
• Used in controlled reconstitution of proteoliposomes or supported bilayer systems

Final product types

• Artificial lipid vesicles for research assay kits
• Planar lipid bilayer supports for electrophysiology
• Model membranes for protein interaction screening